Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
0.066 AUD -0.00 ( 2.94%)
Last update at 2026-11-12T05:10:00Z
VOLUME
10196
Market Cap
8.76M

Momentum Score

…

TALi Digital Limited, a digital health company, delivers diagnostic and therapeutic solutions to enhance attention cognitive function in Australia, New Zealand, and internationally. It offers ReadyAttentionGo!, a medical device that is a digital therapeutic cognitive training program designed to improve attention skills in children aged 3 to 10 years old; TALi Research and Development!; and You Can Do It! Education, an online social-emotional learning and mental health program for children and adolescents. The company was formerly known as Novita Healthcare Limited and changed its name to TALI Digital Limited in December 2019. TALi Digital Limited was incorporated in 2004 and is based in Hawthorn East, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.07
Low
0.07
High
52 Week Price Range
0.04
Low
0.14
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Tali Digital Ltd (TD1.AU) is limited; available disclosures do not provide comprehensive detail about its core operations or market positioning. If the company advances a viable digital services or technology offering and secures stable funding, it may benefit from ongoing digital adoption trends and scalable revenue potential, which could support long-term growth.

Material risks include scarce public disclosure, low trading liquidity, execution and financing uncertainty common to early-stage listed companies, and the possibility of sustained losses or dilutive capital raisings.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.07
Dividend Yield
-
Revenue TTM
0.27M
Revenue Per Share
0.01
Gross Profit TTM
-0.23M
Debt / Equity
0.10
ROE
-151.84%
Net Debt
-0.97M
ROCE
-153.20%
Diluted EPS TTM
-0.05

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -2.43M -0.66M -3.18M -2.26M -5.83M
Net income -2.21M -0.66M -3.12M -2.26M -5.83M
Selling general administrative 0.63M 0.27M 0.48M 1.40M 3.18M
Selling and marketing expenses - - 0.00M 0.19M 1.01M
Gross profit -0.47M 0.00M -0.45M -1.49M -3.59M
Reconciled depreciation 0.16M - 0.18M 0.32M 0.37M
Ebit -0.99M - -1.23M -2.27M -5.76M
Ebitda -0.83M -0.71M -1.05M -1.95M -5.39M
Depreciation and amortization 0.16M - 0.18M 0.32M 0.37M
Operating income -0.99M -0.71M -1.23M -2.27M -6.85M
Other operating expenses 1.26M 0.71M 1.23M -0.02M -0.59M
Interest expense - - - -0.01M 0.07M
Tax provision -0.21M 0.00M 0.00M 0.00M 0.00M
Interest income 0.01M 0.05M 0.08M 0.01M 0.08M
Net interest income 0.01M 0.05M 0.08M 0.01M -0.07M
Extraordinary items - - - - 0.00M
Income tax expense -0.21M - -0.07M 0.75M 0.93M
Total revenue 0.27M 0.00M 0.00M 0.03M 0.01M
Total operating expenses 0.52M 0.71M 1.20M 3.05M 6.63M
Cost of revenue 0.75M - 0.45M 1.52M 3.61M
Total other income expense net -1.44M 0.05M -1.96M 0.76M 0.86M
Net income from continuing ops -2.21M -0.66M -3.12M -2.26M -5.83M
Net income applicable to common shares - -0.66M -3.12M -2.26M -5.83M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 1.08M 2.66M 2.19M 8.09M 7.54M
Intangible assets - - - 4.36M 3.85M
Other current assets 0.02M - 0.00M - 0.38M
Total liab 0.44M 0.39M 0.04M 2.92M 3.01M
Total stockholder equity 0.65M 2.27M 2.15M 5.17M 4.54M
Other current liab 0.19M - 0.03M 0.23M 0.08M
Common stock 216.08M - 214.84M 214.84M 211.04M
Capital stock 216.08M 215.58M - 214.84M 211.04M
Retained earnings -215.78M -213.88M -213.22M -210.13M -207.19M
Other liab - - - 1.96M 1.80M
Good will - 1.31M - - -
Other assets - - - - 0.83M
Cash 0.97M 1.29M 2.12M 2.99M 1.85M
Cash and equivalents - - - - 1.85M
Total current liabilities 0.44M 0.27M 0.04M 0.96M 0.75M
Current deferred revenue 0.19M - - 0.17M 0.15M
Net debt -0.97M - -2.12M -2.48M -1.34M
Short term debt - - - 0.51M 0.04M
Short long term debt - - - 0.51M 0.04M
Short long term debt total - - - 0.51M 0.50M
Other stockholder equity - - - -4.70M -2.74M
Property plant equipment - - - 0.01M 0.03M
Total current assets 1.08M 1.35M 2.19M 3.72M 2.84M
Net tangible assets - - - 0.81M 0.69M
Short term investments 0.00M 0.00M 0.00M 0.00M 0.00M
Net receivables 0.04M 0.03M 0.06M 0.71M 0.61M
Long term debt - - - 0.00M 0.46M
Inventory 0.04M 0.03M - - -0.28M
Accounts payable 0.06M 0.12M 0.01M 0.05M 0.48M
Accumulated other comprehensive income 0.34M - 0.53M 0.47M 0.69M
Non currrent assets other - - - -4.37M 0.83M
Non current assets total 0.00M 1.31M - 4.37M 4.70M
Capital lease obligations - - - - 0.04M
Long term debt total - - - 0.00M 0.46M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments -0.08M -1.10M - -0.82M -0.01M
Change to liabilities - - - -0.12M 0.02M
Total cashflows from investing activities -0.08M -1.10M 0.00M -0.82M -0.01M
Net borrowings - - -0.50M - 0.47M
Total cash from financing activities 0.50M 0.75M -0.50M 3.96M 3.46M
Change to operating activities - - - 0.12M 0.70M
Net income -2.21M -0.66M -3.12M -2.26M -6.94M
Change in cash -0.32M -0.83M -0.86M 1.14M -0.88M
Begin period cash flow 1.29M 2.12M 2.99M 1.85M 2.73M
End period cash flow 0.97M 1.29M 2.12M 2.99M 1.85M
Total cash from operating activities -0.74M -0.47M -0.36M -2.00M -4.33M
Issuance of capital stock 0.58M 0.80M - 4.21M 3.27M
Depreciation 0.16M - 0.18M 0.06M 0.13M
Other cashflows from investing activities - -1.10M - - 0.00M
Change to inventory 0.01M -0.03M - - -
Change to account receivables -0.02M 0.04M 0.65M -0.10M 0.23M
Sale purchase of stock -0.08M -0.05M 0.00M -0.26M -0.28M
Other cashflows from financing activities - -0.05M -0.50M -0.82M 0.47M
Change to netincome - - - 0.04M 0.17M
Capital expenditures 0.00M 0.00M 0.00M 0.82M 0.01M
Change in working capital 0.11M 0.15M 0.33M -0.10M 0.23M
Stock based compensation - - 0.10M 0.04M 0.17M
Other non cash items 1.43M -0.63M 2.14M 0.20M 2.48M
Free cash flow -0.74M -0.47M -0.36M -2.82M -4.34M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
TD1
Tali Digital Ltd
-0.00
2.94%
0.07 - 7.46 31.86 14.20 35.11 -1.56
PME
Pro Medicus Ltd
-4.52
2.18%
202.79 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd
-0.06
2.53%
2.31 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd
0.12
3.30%
3.76 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd
-0.14
3.91%
3.44 - - 20505.14 7.00 16927.51 0.33

Profile*

Tali Digital Ltd

TALi Digital Limited, a digital health company, delivers diagnostic and therapeutic solutions to enhance attention cognitive function in Australia, New Zealand, and internationally. It offers ReadyAttentionGo!, a medical device that is a digital therapeutic cognitive training program designed to improve attention skills in children aged 3 to 10 years old; TALi Research and Development!; and You Can Do It! Education, an online social-emotional learning and mental health program for children and adolescents. The company was formerly known as Novita Healthcare Limited and changed its name to TALI Digital Limited in December 2019. TALi Digital Limited was incorporated in 2004 and is based in Hawthorn East, Australia.

117 Camberwell Road, Hawthorn East, VIC, Australia, 3123

61 3 9192 9937

Name Title Year Born
Dr. Mary Elizabeth Brinson CEO & Chief Medical Officer NA
Ms. Magda Klapakis BSocSc, CPA, PostGradAcc Head of Fin. & Financial Controller NA
Mr. Pete Saunders Chief Operations Officer NA
Paul McKeon Investor Relations Mang. NA
Mr. David Turnbull National Sales Mang. NA
Mr. Lee Simpson Marketing Mang. NA
Mr. Tim Luscombe Company Sec. NA
Mr. M. Rose Exec. Officer NA
Ms. Magda Klapakis BSocSc, CPA, PostGradAcc Head of Finance & Financial Controller NA
Paul McKeon Investor Relations Manager NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…